314.70
2.10 (0.67%)
| Penutupan Terdahulu | 312.60 |
| Buka | 312.79 |
| Jumlah Dagangan | 117,310 |
| Purata Dagangan (3B) | 810,483 |
| Modal Pasaran | 8,729,430,016 |
| Harga / Jualan (P/S) | 842.93 |
| Harga / Buku (P/B) | 24.04 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| Margin Operasi (TTM) | -2,868.84% |
| EPS Cair (TTM) | -10.66 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1,349.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.24% |
| Nisbah Semasa (MRQ) | 8.44 |
| Aliran Tunai Operasi (OCF TTM) | -163.91 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -90.04 M |
| Pulangan Atas Aset (ROA TTM) | -39.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -63.56% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Praxis Precision Medicines, Inc | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | -1.0 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 2.0 |
| Purata | -1.10 |
|
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.16% |
| % Dimiliki oleh Institusi | 122.02% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 843.00 (BTIG, 167.87%) | Beli |
| Median | 450.00 (42.99%) | |
| Rendah | 95.00 (Wedbush, -69.81%) | Jual |
| Purata | 489.56 (55.56%) | |
| Jumlah | 8 Beli, 1 Jual | |
| Harga Purata @ Panggilan | 272.99 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wedbush | 12 Jan 2026 | 95.00 (-69.81%) | Jual | 275.74 |
| 05 Dec 2025 | 83.00 (-73.63%) | Jual | 247.99 | |
| BTIG | 29 Dec 2025 | 843.00 (167.87%) | Beli | 304.58 |
| 08 Dec 2025 | 507.00 (61.11%) | Beli | 270.98 | |
| Oppenheimer | 15 Dec 2025 | 750.00 (138.32%) | Beli | 276.40 |
| Guggenheim | 09 Dec 2025 | 760.00 (141.50%) | Beli | 258.13 |
| Jefferies | 09 Dec 2025 | 450.00 (42.99%) | Beli | 258.13 |
| HC Wainwright & Co. | 08 Dec 2025 | 340.00 (8.04%) | Beli | 270.98 |
| 05 Dec 2025 | 340.00 (8.04%) | Beli | 247.99 | |
| Needham | 08 Dec 2025 | 315.00 (0.10%) | Beli | 270.98 |
| 05 Dec 2025 | 304.00 (-3.40%) | Beli | 247.99 | |
| TD Cowen | 08 Dec 2025 | 353.00 (12.17%) | Beli | 270.98 |
| Truist Securities | 08 Dec 2025 | 500.00 (58.88%) | Beli | 270.98 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KELLY TIMOTHY EDWIN | - | 282.10 | -2,278 | -645,104 |
| MASTROCOLA LAUREN | - | 282.10 | -711 | -200,716 |
| NEMIROFF ALEX | - | 282.10 | -1,685 | -476,277 |
| SNIECINSKI MEGAN | - | 282.10 | -1,972 | -557,575 |
| SOUZA MARCIO | - | 288.45 | -4,252 | -1,226,489 |
| Jumlah Keseluruhan Kuantiti Bersih | -10,898 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -3,106,161 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 282.80 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| KELLY TIMOTHY EDWIN | Pegawai | 12 Jan 2026 | Dibuang (-) | 943 | 275.74 | 260,023 |
| NEMIROFF ALEX | Pegawai | 12 Jan 2026 | Dibuang (-) | 768 | 275.74 | 211,768 |
| SNIECINSKI MEGAN | Pegawai | 12 Jan 2026 | Dibuang (-) | 885 | 275.74 | 244,030 |
| MASTROCOLA LAUREN | Pegawai | 12 Jan 2026 | Dibuang (-) | 344 | 275.74 | 94,855 |
| SOUZA MARCIO | Pegawai | 10 Jan 2026 | Dibuang (-) | 4,252 | 288.45 | 1,226,489 |
| KELLY TIMOTHY EDWIN | Pegawai | 10 Jan 2026 | Dibuang (-) | 1,335 | 288.45 | 385,081 |
| NEMIROFF ALEX | Pegawai | 10 Jan 2026 | Dibuang (-) | 917 | 288.45 | 264,509 |
| SNIECINSKI MEGAN | Pegawai | 10 Jan 2026 | Dibuang (-) | 1,087 | 288.45 | 313,545 |
| MASTROCOLA LAUREN | Pegawai | 10 Jan 2026 | Dibuang (-) | 367 | 288.45 | 105,861 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |